Overview
Key Metrics Quarterly
P&L
Balance Sheet
Cash Flows
Ratios
Shareholding
Documents
About
Laurus Labs Limited, together with its subsidiaries, manufactures and sells medicines and active pharmaceutical ingredients (APIs) in India and internationally. The company offers Generics APIs and solid oral drug products for intermediates for anti-retroviral (ARV), anti-diabetic, cardiovascular, anti-asthma, ophthalmology, oncology, and gastroenterology. It also develops and manufactures animal-origin-free recombinant proteins and cell-culture media supplements and research and development services, including drug substance development, drug product development, and biologics development. In addition, the company offers non-human ingredients; rare disease therapeutics; and finished dosages. Laurus Labs Limited was incorporated in 2005 and is based in Hyderabad, India.
Key Metrics
as of Sep 2026
Market Cap 99,224 Cr
P/E 90.80
Div Yield 0.11 %
Book Value βΉ98.20
52w High βΉ1,949.00
52w Low βΉ823.00
Face Value βΉ2.00
Quarterly Results
Rs. Crores Β· hover row for definition
Metric
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Jun 2023
Sales
1,757.00
1,580.00
1,509.00
1,567.00
1,433.00
1,650.00
1,265.00
1,185.00
1,117.00
1,415.00
1,132.00
1,158.00
1,108.00
Expenses
1,258.00
1,205.00
1,164.00
1,177.00
1,105.00
1,255.00
1,059.00
1,003.00
956.00
1,143.00
962.00
978.00
980.00
Operating Profit
499.00
375.00
346.00
390.00
327.00
395.00
206.00
182.00
161.00
271.00
170.00
181.00
128.00
OPM %
28.00
24.00
23.00
25.00
23.00
24.00
16.00
15.00
14.00
19.00
15.00
16.00
12.00
Other Income
20.00
13.00
14.00
28.00
22.00
72.00
7.00
12.00
9.00
24.00
11.00
6.00
7.00
Depreciation
96.00
95.00
94.00
96.00
94.00
88.00
89.00
91.00
91.00
89.00
87.00
85.00
84.00
Interest
35.00
34.00
31.00
34.00
44.00
49.00
48.00
45.00
41.00
42.00
38.00
38.00
33.00
Profit before tax
388.00
259.00
234.00
289.00
211.00
330.00
77.00
58.00
39.00
164.00
57.00
63.00
17.00
Tax %
25.00
26.00
25.00
25.00
25.00
24.00
25.00
27.00
26.00
26.00
25.00
26.00
24.00
Net Profit
290.00
192.00
175.00
216.00
158.00
252.00
57.00
42.00
29.00
121.00
43.00
47.00
13.00
EPS in Rs
5.37
3.55
3.24
4.00
2.93
4.67
1.06
0.79
0.53
2.25
0.79
0.87
0.24
Profit & Loss
Annual Β· Rs. Crores
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Sales
6,089.00 5,217.00 4,812.00 5,773.00 4,707.00 4,769.00 2,797.00 2,236.00 2,027.00 1,892.00 1,775.00 1,326.00
Expenses
4,646.00 4,273.00 4,062.00 4,292.00 3,421.00 3,258.00 2,226.00 1,884.00 1,618.00 1,478.00 1,402.00 1,121.00
Operating Profit
1,443.00 944.00 751.00 1,482.00 1,286.00 1,511.00 571.00 352.00 409.00 414.00 372.00 205.00
OPM %
24.00 18.00 16.00 26.00 27.00 32.00 20.00 16.00 20.00 22.00 21.00 15.00
Other Income
73.00 100.00 47.00 16.00 20.00 26.00 5.00 15.00 28.00 32.00 4.00 34.00
Interest
143.00 182.00 151.00 146.00 96.00 66.00 88.00 86.00 75.00 97.00 111.00 106.00
Depreciation
379.00 359.00 345.00 301.00 235.00 197.00 184.00 161.00 121.00 104.00 86.00 61.00
Profit before tax
994.00 504.00 301.00 1,051.00 975.00 1,275.00 304.00 121.00 241.00 245.00 180.00 72.00
Tax %
26.00 24.00 26.00 28.00 23.00 25.00 12.00 22.00 28.00 18.00 19.00 -2.00
Net Profit
740.00 380.00 224.00 760.00 750.00 956.00 267.00 95.00 173.00 200.00 145.00 74.00
EPS in Rs
13.72 7.05 4.15 14.12 13.96 17.82 5.00 1.78 3.27 3.78 18.36 9.47
Dividend Payout %
15.00 17.00 19.00 14.00 14.00 11.00 10.00 17.00 9.00 8.00 2.00 0.00
Balance Sheet
Annual Β· Rs. Crores β latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Equity Capital
108.00 108.00 108.00 108.00 107.00 107.00 107.00 106.00 106.00 106.00 16.00 16.00
Reserves
5,144.00 4,456.00 4,099.00 3,949.00 3,281.00 2,605.00 1,709.00 1,484.00 1,407.00 1,250.00 790.00 645.00
Borrowings
2,080.00 2,380.00 2,110.00 1,714.00 1,653.00 1,411.00 1,051.00 1,009.00 947.00 808.00 1,081.00 888.00
Other Liabilities
2,208.00 1,643.00 1,351.00 1,187.00 1,567.00 1,502.00 872.00 718.00 547.00 509.00 342.00 344.00
Total Liabilities
9,540.00 8,587.00 7,667.00 6,958.00 6,609.00 5,625.00 3,739.00 3,318.00 3,008.00 2,673.00 2,229.00 1,893.00
Fixed Assets
3,041.00 2,888.00 3,036.00 2,884.00 2,186.00 1,818.00 1,694.00 1,599.00 1,448.00 1,193.00 1,014.00 801.00
CWIP
569.00 336.00 156.00 357.00 755.00 324.00 67.00 107.00 163.00 143.00 70.00 107.00
Investments
891.00 740.00 635.00 384.00 362.00 319.00 58.00 58.00 52.00 51.00 26.00 19.00
Other Assets
5,039.00 4,623.00 3,841.00 3,333.00 3,306.00 3,164.00 1,920.00 1,554.00 1,345.00 1,286.00 1,119.00 966.00
Total Assets
9,540.00 8,587.00 7,667.00 6,958.00 6,609.00 5,625.00 3,739.00 3,318.00 3,008.00 2,673.00 2,229.00 1,893.00
Cash Flows
Annual Β· Rs. Crores β latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Cash from Operating Activity
1,385.00 540.00 659.00 882.00 823.00 694.00 345.00 293.00 369.00 321.00 197.00 -59.00
Cash from Investing Activity
-847.00 -592.00 -757.00 -735.00 -837.00 -900.00 -217.00 -257.00 -417.00 -282.00 -315.00 -406.00
Cash from Financing Activity
-551.00 59.00 139.00 -185.00 15.00 243.00 -127.00 -37.00 49.00 -47.00 90.00 486.00
Net Cash Flow
-13.00 8.00 41.00 -39.00 2.00 38.00 0.00 0.00 0.00 -8.00 -27.00 21.00
Free Cash Flow
677.00 258.00 293.00 141.00 62.00 98.00 127.00 42.00 -12.00 50.00 -124.00 -438.00
CFO/OP %
116.00 71.00 101.00 78.00 77.00 61.00 67.00 90.00 105.00 90.00 62.00 -20.00
Ratios
Annual Β· Days / % β latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Debtor Days
121.00 142.00 124.00 94.00 98.00 98.00 102.00 112.00 100.00 108.00 91.00 78.00
Inventory Days
304.00 258.00 258.00 211.00 279.00 257.00 233.00 201.00 199.00 184.00 177.00 210.00
Days Payable
171.00 138.00 151.00 90.00 140.00 194.00 157.00 144.00 106.00 110.00 91.00 101.00
Cash Conversion Cycle
255.00 262.00 231.00 216.00 237.00 161.00 177.00 169.00 193.00 183.00 177.00 187.00
Working Capital Days
64.00 56.00 56.00 67.00 57.00 50.00 19.00 9.00 -7.00 7.00 20.00 0.00
ROCE %
16.00 9.00 8.00 22.00 23.00 38.00 14.00 8.00 14.00 17.00 17.00 15.00
Shareholding Pattern
% holding β latest first
Quarterly
Yearly
Holder
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Promoters
27.47
27.49
27.49
27.60
27.60
27.62
27.62
27.18
27.18
27.18
27.18
27.20
FIIs
28.00
25.82
26.52
26.17
25.70
25.51
25.56
26.08
25.67
25.98
25.39
24.03
DIIs
13.73
13.96
12.42
11.72
11.94
11.78
12.74
13.05
13.56
11.78
11.13
11.01
Public
30.79
32.73
33.57
34.52
34.78
35.09
34.09
33.69
33.59
35.07
36.30
37.75
No. of Shareholders
291,653
292,281
280,756
283,678
280,223
292,905
292,214
309,063
324,059
356,830
382,880
402,640
Corporate Actions
23 records
Back to all stocks